CRP and cancer: It is also suggested that chronic immune stimulation/chronic inflammation and damage in RA may lead to the increased risk of cancer, which supported by the facts that elevated inflammatory biomarkers such as ESR and CRP were associated with increased cancer risk; whereas longer duration corticosteroid therapy were found to be linked with lower lymphoma risk (9, 50).